Ook interessant
AML ELN guidance (2022)
Publication
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
Find out more
ADMIRAL trial (2019)
Publication
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
MAT-BE-XOS-2023-00020 - November 2023